New peripherally-acting oral analgesic agents.
D000284:Administration, Oral; D000700:Analgesics / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004061:Diflunisal / Q000627:therapeutic use; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use; D007216:Indoprofen / Q000627:therapeutic use; D009288:Naproxen / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy*; D010149:Postoperative Pain / Q000188:drug therapy; D014046:Tolmetin / Q000031:analogs & derivatives / Q000627:therapeutic use
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009288:Naproxen; D004061:Diflunisal; C020549:zomepirac; D007216:Indoprofen; D014046:Tolmetin; D001241:Aspirin; D007052:Ibuprofen